| 1.5 |
4.5 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.0 |
3.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.0 |
2.9 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.9 |
2.8 |
GO:0002894 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.8 |
2.4 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.8 |
3.9 |
GO:0052250 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.7 |
3.6 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.7 |
1.4 |
GO:1902991 |
regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 0.7 |
3.5 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.6 |
1.9 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.6 |
1.9 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.6 |
1.9 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.6 |
1.8 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.5 |
1.6 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.5 |
2.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.5 |
1.5 |
GO:0071423 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.5 |
2.0 |
GO:0090678 |
response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.5 |
0.5 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.5 |
1.4 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.5 |
1.9 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.4 |
2.7 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.4 |
1.3 |
GO:0018013 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 |
1.3 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
| 0.4 |
0.4 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.4 |
0.4 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.4 |
1.2 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.4 |
0.4 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.4 |
1.4 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 |
1.8 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 |
1.7 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 |
1.4 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.3 |
2.4 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 |
0.6 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.3 |
1.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.3 |
0.9 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 |
1.2 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.3 |
1.5 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.3 |
0.9 |
GO:1905033 |
regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.3 |
0.6 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.3 |
1.2 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.3 |
1.2 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.3 |
1.8 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
0.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.3 |
0.9 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.3 |
0.6 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.3 |
0.3 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.3 |
0.8 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.3 |
2.5 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.3 |
1.1 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 |
0.8 |
GO:0090291 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.3 |
0.8 |
GO:0090472 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.3 |
1.4 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 |
1.4 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
0.8 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.3 |
1.4 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.3 |
0.8 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.3 |
0.8 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.3 |
2.1 |
GO:0010732 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.3 |
0.8 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 |
1.0 |
GO:0006238 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.3 |
0.8 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.2 |
1.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
0.7 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.2 |
0.7 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
1.5 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.2 |
1.0 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.2 |
2.7 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.2 |
0.7 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.2 |
0.9 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.2 |
0.2 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.2 |
2.1 |
GO:0035931 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.2 |
1.8 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 |
0.7 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.2 |
0.2 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
| 0.2 |
1.1 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.2 |
2.5 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.2 |
0.7 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.2 |
1.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 |
1.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.9 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.2 |
0.7 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
| 0.2 |
0.4 |
GO:0007435 |
salivary gland morphogenesis(GO:0007435) |
| 0.2 |
1.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.9 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.2 |
2.1 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.2 |
0.6 |
GO:0043315 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.2 |
1.0 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
2.9 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.4 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.2 |
0.8 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.2 |
1.0 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.2 |
0.8 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.2 |
0.8 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
0.6 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.2 |
0.2 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
0.8 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
| 0.2 |
0.4 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 |
1.0 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.2 |
0.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.8 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.2 |
0.9 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
0.6 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 |
0.4 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.2 |
0.7 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.2 |
2.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
1.5 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
1.3 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.2 |
0.7 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.2 |
0.2 |
GO:0006808 |
regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.2 |
0.7 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
1.1 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.2 |
0.5 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
1.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
1.1 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.2 |
0.2 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.2 |
1.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
1.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
1.9 |
GO:1904180 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
0.3 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 |
2.9 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 |
0.9 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 |
1.7 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 |
0.2 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 |
1.0 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.2 |
1.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
0.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 |
0.5 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.2 |
0.7 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
0.5 |
GO:1903572 |
regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.2 |
0.5 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.2 |
0.8 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.2 |
0.2 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 |
0.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
0.2 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 |
1.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 |
0.5 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
2.8 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 |
0.8 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.5 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 |
0.5 |
GO:0072738 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 |
1.2 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
2.4 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
2.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.9 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.1 |
1.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.1 |
0.6 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 |
0.9 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
3.8 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.1 |
0.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.1 |
0.7 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.4 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
0.3 |
GO:0002325 |
natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.1 |
5.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.3 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.7 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.4 |
GO:0002885 |
positive regulation of hypersensitivity(GO:0002885) |
| 0.1 |
0.4 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
1.4 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.6 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
1.0 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.7 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.1 |
0.3 |
GO:0072249 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
1.9 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.3 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.1 |
0.4 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
2.3 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.3 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.4 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.5 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
1.2 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
1.0 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.1 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.3 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 |
0.4 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.1 |
0.5 |
GO:0097191 |
extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.1 |
0.3 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.6 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
1.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.5 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.5 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.1 |
4.3 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
0.2 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.2 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.1 |
0.5 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
2.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.2 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.4 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.5 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
1.3 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
10.2 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.6 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.1 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 |
0.4 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 |
0.8 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.4 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.1 |
0.4 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.1 |
0.5 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.1 |
0.4 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.1 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 |
0.5 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.8 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 |
0.5 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
0.2 |
GO:1903521 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 |
0.3 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.1 |
0.6 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.6 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.1 |
0.3 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 |
0.2 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 |
0.4 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 |
0.3 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.4 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.1 |
3.0 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.1 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
0.7 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
2.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
1.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.1 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.3 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.1 |
0.9 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
1.2 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.6 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.1 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.1 |
0.2 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 |
0.2 |
GO:0009608 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 |
2.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.6 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.6 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.4 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.1 |
0.7 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.5 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.1 |
GO:0009447 |
putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.1 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.1 |
0.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.4 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.5 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.1 |
GO:0045073 |
regulation of chemokine biosynthetic process(GO:0045073) |
| 0.1 |
0.5 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 |
1.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.3 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
0.6 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.6 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
0.3 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.1 |
0.1 |
GO:1903208 |
positive regulation of mast cell cytokine production(GO:0032765) neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.1 |
0.3 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.4 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
0.2 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
0.3 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
0.4 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 |
0.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
0.1 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.1 |
0.6 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.1 |
GO:0060541 |
respiratory system development(GO:0060541) |
| 0.1 |
1.3 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.1 |
0.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
1.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.3 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 |
0.3 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
1.0 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.1 |
0.4 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) |
| 0.1 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.3 |
GO:0051794 |
catagen(GO:0042637) regulation of catagen(GO:0051794) |
| 0.1 |
0.7 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
0.4 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 |
1.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.3 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
1.2 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
1.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.9 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.4 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
5.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.6 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.6 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.2 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
0.9 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
0.3 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.6 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.3 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.2 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
2.0 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.3 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.1 |
0.8 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.2 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.1 |
0.1 |
GO:0002923 |
regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
| 0.1 |
0.9 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 |
0.7 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.1 |
0.3 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.1 |
0.7 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.3 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.3 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.1 |
0.4 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.1 |
0.6 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
2.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.4 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.3 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 0.1 |
0.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.2 |
GO:1902566 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:2000592 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.4 |
GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 |
0.2 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.1 |
1.2 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.1 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.2 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.1 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.9 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.3 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
0.5 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.9 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.1 |
GO:0100012 |
regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 0.1 |
0.2 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.1 |
0.6 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.2 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.5 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.6 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 |
0.8 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:0006562 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.1 |
0.2 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.2 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.1 |
0.2 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
4.2 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.4 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.1 |
0.2 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.1 |
0.2 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 |
0.3 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
1.0 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.5 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.1 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 |
0.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
1.3 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.2 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 |
0.4 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.9 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.6 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.6 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.3 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.1 |
0.5 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.4 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.1 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.1 |
GO:0032105 |
negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.1 |
0.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
2.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.1 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.4 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.3 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.5 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.8 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.8 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) |
| 0.1 |
0.4 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.1 |
0.4 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.1 |
0.1 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.1 |
0.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
1.2 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.8 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.1 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.2 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.2 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.3 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 |
0.4 |
GO:0015692 |
lead ion transport(GO:0015692) |
| 0.1 |
0.1 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.2 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.1 |
0.4 |
GO:0036017 |
response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.1 |
0.1 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
0.1 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
0.3 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.2 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
0.7 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:0039521 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
| 0.1 |
0.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.2 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
0.1 |
GO:0033122 |
regulation of cyclic nucleotide catabolic process(GO:0030805) negative regulation of cyclic nucleotide catabolic process(GO:0030806) regulation of cAMP catabolic process(GO:0030820) negative regulation of cAMP catabolic process(GO:0030821) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.1 |
0.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.2 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
1.0 |
GO:1901538 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.3 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
0.7 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.3 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
1.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.1 |
0.3 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.4 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
1.0 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.1 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.1 |
1.1 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
0.5 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.1 |
0.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.5 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.1 |
0.4 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.2 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 |
1.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
2.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.1 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.1 |
0.1 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.1 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 |
0.1 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
0.4 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 |
0.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.3 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.1 |
0.1 |
GO:0090210 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.3 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.1 |
GO:0072025 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.1 |
0.2 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 |
0.5 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.1 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 |
0.6 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.2 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 |
0.1 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.1 |
0.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.2 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
0.2 |
GO:0043305 |
negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.7 |
GO:0072540 |
T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 |
0.2 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.2 |
GO:0071733 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 |
0.4 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.8 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.5 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.1 |
0.4 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.1 |
0.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
2.1 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.8 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.3 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
1.2 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
0.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
0.2 |
GO:0021930 |
cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
0.2 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.2 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.9 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.2 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.3 |
GO:0045764 |
positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.1 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.3 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 |
0.1 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.1 |
0.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 |
0.1 |
GO:0080184 |
response to phenylpropanoid(GO:0080184) |
| 0.1 |
0.1 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.5 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.1 |
0.2 |
GO:1904351 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.4 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.7 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
1.5 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 |
0.1 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.1 |
0.3 |
GO:0036079 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.2 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.1 |
0.7 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
0.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
1.6 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
0.3 |
GO:1902460 |
transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 |
0.3 |
GO:0007068 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
0.2 |
GO:0090277 |
positive regulation of peptide hormone secretion(GO:0090277) |
| 0.1 |
1.7 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
1.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.2 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.2 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.4 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.2 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.1 |
0.1 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.1 |
0.1 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.4 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 |
0.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 |
0.4 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.5 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 |
1.0 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.4 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.3 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
4.8 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0030195 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.2 |
GO:0030818 |
negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 |
1.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.5 |
GO:0098659 |
inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
| 0.0 |
1.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.4 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
1.0 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.5 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.0 |
0.1 |
GO:1904530 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 |
1.0 |
GO:0070571 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.2 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.2 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 |
0.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
1.2 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 |
0.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.1 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.0 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.1 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.3 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.5 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.1 |
GO:0071221 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 0.0 |
0.4 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.0 |
0.2 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.0 |
0.1 |
GO:0002475 |
antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.0 |
0.1 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.5 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.1 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 |
5.2 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.2 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 |
0.8 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.1 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.0 |
0.6 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.2 |
GO:0030311 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.0 |
0.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.3 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.3 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
1.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.5 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.7 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.5 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.8 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.0 |
0.1 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 |
0.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
2.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.2 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.3 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.1 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.0 |
0.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.0 |
0.4 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.2 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.0 |
0.0 |
GO:2001279 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.0 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
0.2 |
GO:0021816 |
lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.0 |
0.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.0 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.0 |
0.2 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.1 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.0 |
0.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 |
0.2 |
GO:1901093 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.0 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.0 |
0.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
0.2 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 |
0.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.2 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.2 |
GO:0070843 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.0 |
0.7 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.2 |
GO:0048205 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.1 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.7 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 |
0.5 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.2 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.8 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
1.3 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.3 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.3 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
0.2 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.0 |
0.6 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 |
0.0 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.3 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
0.0 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.0 |
0.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.2 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
0.1 |
GO:0097065 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.0 |
0.2 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.1 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.0 |
0.1 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.4 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
1.1 |
GO:0006735 |
NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.4 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 |
0.0 |
GO:0038194 |
thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.0 |
1.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.3 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.5 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 |
0.2 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.0 |
0.1 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.0 |
0.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.0 |
0.1 |
GO:0045990 |
carbon catabolite regulation of transcription(GO:0045990) |
| 0.0 |
0.2 |
GO:1902692 |
negative regulation of neuroblast proliferation(GO:0007406) regulation of neuroblast proliferation(GO:1902692) |
| 0.0 |
0.3 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.3 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.2 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.2 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.0 |
0.2 |
GO:0045337 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.0 |
0.1 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.0 |
1.5 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 |
0.0 |
GO:1900244 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.0 |
0.1 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.7 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.2 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.3 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.2 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.4 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.0 |
0.8 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.1 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 |
0.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.0 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.1 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.0 |
0.2 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.6 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.2 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.2 |
GO:0009615 |
response to virus(GO:0009615) |
| 0.0 |
2.9 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.1 |
GO:0001889 |
liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:1904385 |
cellular response to angiotensin(GO:1904385) |
| 0.0 |
0.2 |
GO:0015727 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.4 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.0 |
0.1 |
GO:0032986 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.3 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.0 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.1 |
GO:0071941 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.1 |
GO:0060319 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil differentiation(GO:0030222) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) |
| 0.0 |
0.6 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.5 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.2 |
GO:0098868 |
endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.0 |
0.2 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 |
0.2 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.1 |
GO:0051808 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.0 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.1 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.0 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.3 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
3.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.1 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.0 |
0.1 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 |
0.1 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 |
0.1 |
GO:1904566 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.0 |
0.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 |
1.1 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.4 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.6 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.2 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.0 |
0.8 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.5 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.0 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.3 |
GO:0098870 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.2 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.0 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.2 |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration(GO:0007204) |
| 0.0 |
0.0 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.0 |
0.1 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.8 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.7 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.2 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.9 |
GO:0009251 |
glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 |
0.0 |
GO:1902866 |
regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) regulation of amacrine cell differentiation(GO:1902869) |
| 0.0 |
0.4 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.3 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 |
0.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.6 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 |
0.1 |
GO:1900365 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.5 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
1.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.0 |
0.3 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.7 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.0 |
0.2 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
0.1 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.0 |
0.1 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 |
0.2 |
GO:0045006 |
DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 0.0 |
0.6 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.5 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.2 |
GO:0072619 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.1 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.4 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.8 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.1 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 |
0.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.0 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.2 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.1 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.0 |
0.1 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.0 |
0.1 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.0 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) positive regulation of oocyte maturation(GO:1900195) |
| 0.0 |
0.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.0 |
0.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.0 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.0 |
0.0 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.0 |
0.1 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.0 |
0.4 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.3 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.1 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.0 |
0.1 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.0 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.3 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
1.4 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.3 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.5 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.0 |
0.3 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.0 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.1 |
GO:1990668 |
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.0 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.0 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.0 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.0 |
0.1 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.0 |
0.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.0 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.1 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.0 |
0.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.0 |
0.0 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.0 |
2.2 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.1 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.2 |
GO:0044036 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.1 |
GO:1900006 |
positive regulation of dendrite development(GO:1900006) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.1 |
GO:0003188 |
heart valve formation(GO:0003188) |
| 0.0 |
0.1 |
GO:0035822 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.0 |
0.0 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.0 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.2 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.4 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.2 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
1.0 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.5 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.3 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.0 |
2.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.3 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
1.5 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.0 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.0 |
0.1 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.0 |
0.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:0070977 |
ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
| 0.0 |
0.1 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.4 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:0035588 |
G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.4 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
0.1 |
GO:0048807 |
ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.1 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.0 |
0.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:0043301 |
negative regulation of leukocyte degranulation(GO:0043301) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.1 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.2 |
GO:1903543 |
positive regulation of exosomal secretion(GO:1903543) |
| 0.0 |
0.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.3 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.2 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.1 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 |
0.3 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.1 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.1 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.0 |
0.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.1 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.1 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.1 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.0 |
0.1 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.0 |
0.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.1 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.0 |
0.0 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.0 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.0 |
0.1 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 |
0.3 |
GO:0015758 |
glucose transport(GO:0015758) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.0 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.0 |
0.2 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.1 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.0 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.1 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.1 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.0 |
0.2 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0030902 |
hindbrain development(GO:0030902) |
| 0.0 |
0.0 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.0 |
0.0 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.0 |
0.4 |
GO:0001958 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.1 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.0 |
0.2 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.1 |
GO:0060972 |
left/right pattern formation(GO:0060972) left/right axis specification(GO:0070986) |
| 0.0 |
0.5 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
1.3 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.0 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.4 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.0 |
0.0 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.3 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.0 |
GO:0006538 |
glutamate catabolic process(GO:0006538) glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.0 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 |
0.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.0 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 |
0.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.8 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.0 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.0 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.7 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.1 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.0 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.1 |
GO:0045199 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.1 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.0 |
0.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 |
0.3 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.4 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.0 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.0 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.0 |
0.1 |
GO:0051480 |
regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.0 |
0.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 |
0.2 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.2 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.0 |
0.1 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.0 |
GO:0072511 |
divalent inorganic cation transport(GO:0072511) |
| 0.0 |
0.6 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.0 |
0.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
0.2 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
0.2 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.0 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.1 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.0 |
GO:0006738 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.0 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.0 |
0.1 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.0 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) |
| 0.0 |
0.1 |
GO:0051023 |
regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 |
0.2 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.1 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.0 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.0 |
GO:0002370 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.0 |
0.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
| 0.0 |
0.1 |
GO:0007567 |
parturition(GO:0007567) |
| 0.0 |
0.2 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.0 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.0 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.1 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.0 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.1 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.0 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.0 |
GO:0046098 |
guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.0 |
0.1 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.0 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.1 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.1 |
GO:0007207 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.1 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
0.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.0 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.1 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.0 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 |
0.0 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.0 |
0.0 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.0 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.0 |
0.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.0 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.0 |
GO:0051904 |
pigment granule transport(GO:0051904) |
| 0.0 |
0.0 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
0.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
1.4 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.0 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.0 |
0.1 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.2 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.3 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.0 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.0 |
GO:0043474 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.0 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.0 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.0 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 |
0.0 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
